CLINICAL TRIALS PROFILE FOR VANCENASE AQ
✉ Email this page to a colleague
All Clinical Trials for VANCENASE AQ
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00489203 ↗ | Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer | Completed | Fred Hutchinson Cancer Research Center | Phase 2 | 2007-04-01 | RATIONALE: Beclomethasone dipropionate may be effective in preventing acute graft-versus-host disease in patients undergoing a stem cell transplant for hematologic cancer. PURPOSE: This randomized phase II trial is studying how well beclomethasone dipropionate works in preventing acute graft-versus-host disease in patients undergoing a donor stem cell transplant for hematologic cancer. |
NCT03855189 ↗ | Safety and Efficacy of Mometasone Furoate (SCH 032088) vs Beclomethasone Dipropionate or Placebo in Seasonal Allergic Rhinitis (C93-013) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 1993-08-23 | The objectives of this study are to determine the safety and efficacy in seasonal allergic rhinitis of a four-week course of mometasone furoate compared to beclomethasone dipropionate or placebo. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for VANCENASE AQ
Condition Name
Condition Name for VANCENASE AQ | |
Intervention | Trials |
Primary Myelofibrosis | 1 |
Stage I Adult T-cell Leukemia/Lymphoma | 1 |
Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma | 1 |
Stage III Marginal Zone Lymphoma | 1 |
[disabled in preview] | 0 |
This preview shows a limited data set Subscribe for full access, or try a Trial |
Clinical Trial Locations for VANCENASE AQ
Trials by Country
Clinical Trial Progress for VANCENASE AQ
Clinical Trial Phase
Clinical Trial Sponsors for VANCENASE AQ
Sponsor Name